---
document_datetime: 2025-09-29 08:40:18
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/xalkori-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: xalkori-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6894403
conversion_datetime: 2025-12-27 14:48:52.563904
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## XALKORI

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 19/09/2025                          | N/A                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000293229                     | PRODUCTS - C.I.z Other variation - Accepted C.I.z - to include the compliance statement of the agreed PIP P/0036/2021.                                                                                                                                                                                                                                                                                                                                                                                                    |            |     |                 |                   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------|-------------------|
| Variation type IA_IN /                | B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.1 Not including batch control/testing - Accepted                                                                                                                                                                                                                                                                                                                                                       | 11/09/2025 |     | Annex II and PL | EMA/VR/0000278463 |
| Variation type IA / EMA/VR/0000287195 | B.II.d.2 Change in test procedure for the finished product - B.II.d.2.a Minor changes to an approved test procedure - Accepted                                                                                                                                                                                                                                                                                                                                                                                            | 21/07/2025 | N/A |                 |                   |
| Variation type IA / EMA/VR/0000237698 | A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted | 07/03/2025 | N/A |                 |                   |
| Article 61(3) / EMA/N/0000246187      | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representative and deletion of 'United Kingdom (Northern                                                                                                                                                                                                                                                                                                                                                 | 25/02/2025 |     | PL              |                   |

<div style=\"page-break-after: always\"></div>

| Ireland)' from the list of local representatives in line with the QRD template v10.4.   |
|-----------------------------------------------------------------------------------------|